Invicta Diagnostic IPO closes with 4x subscription across investor categories

Invicta Diagnostic’s SME IPO closed on December 5 at ₹85 per share with 4.05x overall subscription. Investors showed interest in the company’s pathology and diagnostics expansion plan supported by rising demand from tier-2 and tier-3 markets. The allotment date is set for December 8, with listing expected shortly after.